What's new

Human medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation: 17/05/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation: 17/05/2024, Revision: 4, Status: Authorised

Apr 11, 2025 - 15:30
 0
Human medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation: 17/05/2024, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation: 17/05/2024, Revision: 4, Status: Authorised
Read More

Tags:

Previous Article

As work on massive US plant continues, Kyowa Kirin wraps up construction of $118...

Next Article

Luctaboost™: Enhancing Flavor & Reducing Cost for Smarter Formulation

Related Posts

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 5 December 2024, 09:30 (CET) to 5 December 2024, 13:30 (CET)

Meeting of the Medicine Shortages Single Point of Conta...

Feb 10, 2025  0

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025  0

Human medicines European public assessment report (EPAR): Jalra, vildagliptin, Date of authorisation: 19/11/2008, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0